Efficacy and tolerability of pharmacotherapy for post-stroke depression: a network meta-analysis.
Conclusions: Paroxetine is probably the best option to consider for patients with PSD. To get a quicker relief of depression, duloxetine might be useful for its rapid onset of antidepressant action. The tolerability was comparable among all the antidepressants. But more high-quality RCTs are needed.
PMID: 29805769 [PubMed]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research
More News: Celexa | Citalopram | Cymbalta | Databases & Libraries | Depression | Disability | Fluoxetine | Imipramine | Nortriptyline | Paroxetine | Paxil | Prozac | Stroke | Study